Skip to main content

Table 1 Baseline comparison of medical practice and researcher group patients. Values are numbers (percentages) unless stated otherwise.

From: Does it matter whether the recipient of patient questionnaires in general practice is the general practitioner or an independent researcher? The REPLY randomised trial

Characteristic

Medical Practice (n = 132)

Researcher (n = 142)

Female

82 (62.1)

88 (62.0)

Median (Q1–Q3) Age (years)

62.0 (51.3–74.8)

65.0 (54.0–74.0)

Living alone

23 (17.4)

25 (17.6)

Median (Q1–Q3) Daily drugs

3.0 (2.0–5.8)

3.0 (2.0–5.0)

Median (Q1–Q3) PRN drugs

1.0 (0.0–1.0)

1.0 (0.0–2.0)

Active problems

  

Diseases of circulatory system

89 (67.4)

92 (64.8)

   Hypertension

51 (38.6)

55 (38.7)

   Ischemic Heart Disease

18 (13.6)

13 (9.2)

   Cerebrovascular Disease

13 (9.8)

12 (8.5)

   Other forms of heart disease

7 (5.3)

12 (8.5)

Asthma/COPD

29 (21.9)

35 (24.6)

Diabetes Mellitus

23 (17.4)

23 (16.2)

Disorders of the thyroid gland

14 (10.6)

12 (8.5)

Mood [affective] disorders

16 (12.1)

21 (14.8)

Eye & adnexa

12 (9.1)

14 (9.9)

Digestive system

25 (18.9)

29 (20.4)

Skin & subcutaneous tissue

11 (8.3)

10 (7.0)

Musculatory system & connective tissue

34 (25.8)

44 (30.9)

Genitourinary

24 (18.2)

23 (16.2)

Other

34 (25.8)

23 (16.2)

Newly prescribed medication

  

Cardiovascular system

66 (50.0)

70 (49.3)

   Diuretics

3 (2.3)

12 (8.5)

   Beta-blockers

5 (3.8)

9 (6.3)

   ACE inhibitors or ARAs

21 (15.9)

12 (8.5)

   Calcium-channel blockers

3 (2.3)

14 (9.9)

   Lipid regulating drugs

19 (14.4)

12 (8.5)

Respiratory system

14 (10.6)

10 (7.0)

Central nervous system

12 (9.1)

12 (8.5)

Endocrine system

18 (13.6)

21 (14.8)

Obstetrics & gynaecology

13 (9.8)

14 (9.9)

Others

9 (6.8)

15 (10.6)

Dosage form

  

Tablets or Capsules

114 (86.4)

132 (93.0)

Inhalers

13 (9.8)

8 (5.6)

Others

5 (3.8)

2 (1.4)

Dosage frequency

  

Less than daily

4 (3.0)

6 (4.2)

Daily

103 (78.0)

118 (83.1)

More than daily

24 (18.2)

17 (12.0)

Unknown

1 (0.8)

1 (0.7)

  1. (Q1–Q3) = lower quartile – upper quartile
  2. ACE = Angiotensin-converting enzyme inhibitors
  3. ARAs = Angiotensin-II receptor antagonists
Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us